Mangoes, the ‘king of fruits’, tantalize taste buds with their perfect blend of sweetness and tang. But for those embarking on the journey of motherhood, a pressing question often arises: Is it safe to consume mango in early pregnancy? Let’s delve deeper. Mango in Early Pregnancy : Nutritional Boon Mangoes bring more to the table […]
In a significant development for diabetes treatment in the U.S., Dr. Reddy’s Laboratories has unveiled its Saxagliptin and Metformin Hydrochloride Extended-Release Tablets. This launch introduces a therapeutic equivalent to the widely prescribed KOMBIGLYZE XR (saxagliptin and metformin hydrochloride extended release) tablets, with the endorsement of the US Food and Drug Administration (FDA). The Indian pharmaceutical […]
TheracosBio announced the publication of a 24-week randomized, double-blind, placebo-controlled trial, proving Bexagliflozin’s effectiveness as an adjunct to Metformin for treating adults with type 2 diabetes. The Phase 3 study, published in “Diabetes, Obesity and Metabolism,” highlights the positive impact of BRENZAVVY (bexagliflozin), 20 mg, in improving glycemic control and reducing systolic blood pressure levels. […]
Eli Lilly and Company has unveiled the results of two Phase 3 tirzepatide studies (SURMOUNT-3 and SURMOUNT-4) targeting adults with obesity or overweight with weight-related comorbidities, excluding type 2 diabetes. Both studies successfully met all primary and key secondary objectives, showcasing the effectiveness of tirzepatide over a placebo. The results saw participants on tirzepatide, after […]
Dexcom, a notable player in real-time continuous glucose monitoring (rtCGM) globally, confirmed today that Health Canada has given its approval for the next-generation Dexcom G7 Continuous Glucose Monitoring System. The product is intended for people aged two and above who have any type of diabetes. Dexcom Canada, however, has mentioned that the device is not […]
Sun Pharmaceutical Industries has unveiled positive results from two Phase 1 studies assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of GL0034, a novel long-acting GLP-1 receptor agonist, in non-obese and obese adults without diabetes. The findings will be presented in poster sessions at the American Diabetes Association’s 83rd Scientific Sessions in San Diego. One of […]
Ireland-based healthcare technology company Medtronic has announced an agreement to acquire EOFlow, a South Korean medical device company, for a total consideration of KRW 971 billion ($738 million). This acquisition marks Medtronic’s move to expand its capabilities in addressing the needs of individuals with diabetes. South Korean medical device innovation in diabetes care Founded in […]
Eli Lilly and Company (Lilly) has agreed to sell its severe hypoglycemia drug BAQSIMI to Amphastar Pharmaceuticals in a deal potentially worth up to $1.07 billion. BAQSIMI is indicated for the treatment of severe hypoglycemia, which is very low blood sugar, in people with diabetes aged four years and over. It is the first as […]
Zydus Lifesciences said that its subsidiary Zydus Pharmaceuticals (USA) has been granted tentative approval for Canagliflozin and Metformin Hydrochloride Tablets, 50mg/500mg, 50mg/1,000mg, 150mg/500mg, and 150mg/1,000mg from the US States Food and Drug Administration (FDA). The Canagliflozin and Metformin Hydrochloride regimen is a generic version of Invokamet Tablets. It is intended to be used as an […]
Glenmark Pharmaceuticals Inc., USA has secured a second tentative approval from the United States Food and Drug Administration (FDA) for Saxagliptin Tablets, 2.5 mg and 5 mg. The product that has been approved is the generic version of type 2 diabetes drug Onglyza Tablets. 2.5 mg, and five mg, from AstraZeneca. The first tentative approval […]